- Business Wire•21 days ago
Verastem, Inc. , focused on discovering and developing drugs to treat cancer, today announced that the company will present at the Rodman & Renshaw 18th Annual Global Investment Conference on Tuesday, September 13th at 10:25 AM Eastern Time at The Lotte New York Palace Hotel.
- Associated Press•2 months ago
On a per-share basis, the Needham, Massachusetts-based company said it had a loss of 23 cents. Losses, adjusted for stock option expense, were 18 cents per share. The results exceeded Wall Street expectations. ...
- Business Wire•2 months ago
Verastem, Inc. , focused on discovering and developing drugs to treat cancer, today reported financial results for the second quarter ended June 30, 2016, and also provided an overview of certain corporate developments.
Verastem, Inc. (VSTM)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
|Bid||1.37 x 3100|
|Ask||1.45 x 4000|
|Day's Range||1.36 - 1.40|
|52wk Range||1.05 - 2.43|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-1.15|
|Avg Vol (3m)||219,745|
|Dividend & Yield||N/A (N/A)|